Home›Stock Screener›Span Divergent

Span Divergent Share Price Today | Stock Price & Span Divergent Share Screener

SDL Pharmaceuticals
Live Share Price BSE
₹21.81
▼ -1.14 (-4.97%)
2026-10-05 00:00:00

As of October 5, 2026, the live Span Divergent share price (BSE: SDL) is ₹21.81, down 4.97% from the previous close, with shares trading between ₹21.81 and ₹24.08 in today's trading session, and a 52-week range of ₹21.76–₹49.11. Check Span Divergent yearly highs lows for the annual price range and momentum. Use the Span Divergent stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Span Divergent opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Span Divergent Market Cap ₹19.20 Cr.
SDL P/E Ratio (TTM) 15.00
Span Divergent P/B Ratio -6.32
EPS (TTM) ₹-2.33
Dividend Yield -
Debt to Equity -
SDL 52 Week High ₹49.11
Span Divergent 52 Week Low ₹21.76
Operating Margin -1.00%
Profit Margin -
SDL Revenue (TTM) ₹8.00
EBITDA -
Net Income -
Total Assets ₹23.00
Total Equity ₹-9.00

Span Divergent Share Price Chart

Track the current stock price of Span Divergent with an interactive chart. Analyse SDL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Span Divergent stock quote in one place.

The quote of ₹21.81 sits between the 52-week low of ₹21.76 and the 52-week high of ₹49.11, and the latest session moved -4.97% from the previous close.

Span Divergent Company Profile - Fundamental Screener

Screen Span Divergent company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SDL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE004E01016.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE004E01016

Span Divergent Balance Sheet Screener

Screen SDL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹23 against total liabilities of ₹23, down from ₹24 in 2024.

Latest statistics put total assets at ₹23 and shareholder funds at ₹-9.

Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016

Assets

Total Assets 23 24 26 28 34 40 49 63 65 51
Current Assets 12 12 12 12 16 18 25 36 37 38
Fixed Assets 10 11 13 15 18 20 23 26 8 2

Liabilities

Total Liabilities 23 24 26 28 34 40 49 63 65 51
Current Liabilities 4 5 6 8 13 11 8 9 7 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity -9 -8 -8 -3 7 13 22 36 49 50
Share Capital 6 6 6 6 6 6 6 6 6 6
Reserves & Surplus -8 -7 -8 -3 7 12 20 31 43 45

Span Divergent Income Statement Screener - Profit & Revenue Analysis

Screen Span Divergent income statement and profit fundamentals. Analyze SDL quarterly results. Span Divergent reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2025-Sept, revenue was ₹8 and net profit was ₹0, equal to earnings per unit of ₹-0.34, at an operating margin of -1%.

In that period expenses were ₹8, interest cost ₹0 and tax ₹0. The next period listed, 2025-Jun, shows revenue of ₹2 and net profit of ₹0.

Item 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec 2022-Sept 2022-Jun 2022-Mar

Revenue and Expenses

Revenue 8 2 1 2 3 4 4 3 3 3 4 3 3 3 3
Expenses 8 2 2 2 3 3 3 3 3 3 7 3 4 2 12

Operating Costs and Margins

EBITDA 0 0 -1 0 0 0 1 1 0 1 -3 0 -1 1 -9
Operating Profit % -1.00% -81.00% -198.00% -15.00% 5.00% 2.00% -2.00% 9.00% -8.00% 12.00% -102.00% 4.00% -40.00% 17.00% -341.00%
Depreciation 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 0 -1 0 0 0 1 0 0 0 -4 0 -2 0 -10
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 -1 0 0 0 1 0 0 0 -4 0 -2 0 -10
EPS -0.34 -0.31 -1.87 -0.39 0.09 -0.16 1.62 0.12 -0.55 0.35 -6.61 -0.47 -2.91 0.07 -17.37

Span Divergent Cash Flow Screener - Liquidity Fundamentals

Screen SDL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹2.

Over the same period, investing activities used ₹1 and financing activities used ₹1.

Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March

Cash from Operations and Investing

Operating Activities 2 3 2 7 0 0 -7 -12 -5 -7
Investing Activities -1 0 1 -2 2 6 10 1 -6 13

Financing and Net Cash

Financing Activities -1 -2 -2 -6 -1 -7 -3 7 13 -12
Net Cash Flow 0 1 0 -1 0 -2 0 -4 2 -6

Span Divergent Shareholding Pattern Screener

See Span Divergent shareholding pattern with promoter, FII, and DII holdings. Check Span Divergent promoter holding and ownership changes for SDL on TickJournal, and see how institutional stock price moves affect the market.

In 2025-Mar, promoters held 64.00%, foreign institutions 0.00%, domestic institutions 0.00% and the public 14.97%, spread across 2,138 shareholders.

The shareholder count was 2,138 in 2025-Mar, compared with 2,140 in 2025-Jun.

Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar

Promoter Holding

Promoter Holding 64.00% 64.00% 64.00% 64.01% 64.01% 64.01% 64.00% 64.01%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 14.97% 14.97% 14.97% 14.94% 14.98% 14.97% 14.97% 15.07%
Other Holding 21.03% 21.02% 21.03% 21.05% 21.02% 21.02% 21.03% 20.92%
Shareholder Count 2,138 2,140 2,156 2,069 2,046 2,072 2,170 2,149

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Span Divergent. Span Divergent dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Span Divergent.

Span Divergent Stock Index Membership - Nifty & Sensex

See which indices include Span Divergent stock. Check SDL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Span Divergent is not part of any tracked indices.
Only major market indices are tracked in our system.

Span Divergent Market Events Screener - Corporate Actions

Get Span Divergent corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Span Divergent stock events that may affect SDL share price, along with derivatives, futures and options activity and sector gainers.

8 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 10, 2025, with a record date of November 10, 2025.

It is followed by Annual General Meeting dated September 29, 2025 and Quarterly Result Announcement dated August 13, 2025.

Announcement Date Record Date Event Type Information Price Impact
2025-11-10 2025-11-10 Quarterly Result Announcement NA -14.20%
2025-09-29 2025-09-29 Annual General Meeting NA 11.43%
2025-08-13 2025-08-13 Quarterly Result Announcement NA 0.15%
2025-05-16 2025-05-16 Quarterly Result Announcement NA 4.96%
2025-02-07 2025-02-07 Quarterly Result Announcement NA -1.65%
2024-10-28 2024-10-28 Quarterly Result Announcement NA -9.19%
2024-09-26 2024-09-26 Annual General Meeting NA 15.85%
2023-09-28 2023-09-28 Annual General Meeting NA -24.12%

Span Divergent Competitors Screener - Peer Stocks Comparison

Screen SDL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 424,634 39.93 54,729 9.71% 10,980 49.55
Divis Laboratories 172,860 69.20 9,712 18.67% 2,191 56.33
Torrent Pharmaceuticals 129,151 60.10 11,539 6.99% 1,911 61.47
Cipla 122,205 22.55 28,410 7.12% 5,291 49.47
Dr Reddys Laboratories 107,114 18.60 33,741 16.73% 5,725 60.05
Lupin 97,120 22.34 22,910 13.74% 3,306 65.28
Zydus Life Science 92,392 18.40 23,511 18.55% 4,615 40.07
Mankind Pharma 90,241 50.59 12,744 20.90% 2,007 45.53
Aurobindo Pharma 71,119 20.79 32,346 9.43% 3,484 59.88
Alkem Laboratories 67,243 27.59 13,458 3.70% 2,216 49.80

Span Divergent Company Announcements - News & Reports Screener

Screen SDL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 26, 2025.

The next most recent announcements are dated November 11, 2025 and November 10, 2025.

Date Update Actions
2025-11-26 Span Divergent Limited - Revised Outcome Of The Board Meeting - November 10 2025 -
2025-11-11 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-10 Span Divergent Limited - Intimation Under Regulation 30 -
2025-11-10 Span Divergent Limited - Intimation For Sell / Transfer Of The Entire Investment Of The Company Held In Span Diagnostics LLP -
2025-11-10 Announcement under Regulation 30 (LODR)-Change in Directorate -
2025-11-10 Span Divergent Limited - Revised Outcome Of Board Meeting Held On November 10 2025 -
2025-11-10 Announcement under Regulation 30 (LODR)-Cessation -
2025-11-10 Announcement under Regulation 30 (LODR)-Cessation -
2025-11-10 Span Divergent Limited - Results For The Quarter Ended On September 30 2025 (Both Standalone And Consolidated) -
2025-11-10 Board Meeting Outcome for Span Divergent Limited - Outcome Of Board Meeting Held On November 10 2025 -
2025-11-06 Update on board meeting -
2025-11-03 Board Meeting Intimation for Board Meeting Of Span Divergent Limited To Be Held On November 10 2025 -
2025-10-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-09-30 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2025-09-30 Announcement under Regulation 30 (LODR)-Change in Management -
2025-09-30 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-09-29 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2025-09-22 Closure of Trading Window -
2025-09-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-09-05 Span Divergent Limited-Notice Of The 45Th Annual General Meeting Of The Company Scheduled To Be Held On Monday September 29 2025 At 11:30 A.M. (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OAVM) -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹21.81, within a 52-week range of ₹21.76 to ₹49.11. The P/E ratio is 15.00 and the P/B ratio is -6.32, with earnings per unit of ₹-2.33. Market capitalisation stands at ₹19.20 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.